John Veranth, Ph.D.

Research Assistant Professor, Department of Pharmacology & Toxicology

Veranth Lab

office: 801-581-3789
fax: 801-585-5111

john.veranth@m.cc.utah.edu

Mailing Address:
Bio-Polymer Research Building 20 S 2030 E Rm 408 Salt Lake City, UT 84112 

Several investigators in the Department of Pharmacology and Toxicology have active research interests related to nanoparticles and nanomedicines, including Drs. Garlod Yost, Philip Moos, N. Shane Cutler, and John Veranth. They have had two EPA-funded projects looking at the toxicology of manufactured nanoparticles in lung, vascular, and colon cells, and are starting a new project looking at the effects of ultrafine diesel emissions on rodent lungs. Research areas of interest include 1) mechanisms of interaction between nanoparticles and cells; 2) gene regulation responses to nanoparticle exposures, with an emphasis on proinflammatory cytokines, growth factors, and oxidative stress response genes; 3) whole animal responses to particle exposure by inhalation and instillation; 4) detection and quantification of nanoparticles in tissues and other biological media.


Akerly
 
Last Updated: 3/14/13